Press Releases

Press Releases

Finch Therapeutics to Participate in Upcoming Investor Conferences
Finch Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates
Finch Therapeutics Announces Transition of Chief Medical Officer
Finch Therapeutics Announces Positive Topline Results from PRISM-EXT Phase 2 Trial of CP101 for Prevention of Recurrent C. difficile Infection
Finch Therapeutics Presents Positive Data from PRISM3 Clinical Trial of CP101 for Recurrent C. difficile at American College of Gastroenterology Annual Scientific Meeting
Finch Therapeutics to Present at the Jefferies Virtual Next Generation IBD Therapeutics Summit
Finch Therapeutics Appoints Samuel Allen Hamood to its Board of Directors
Finch Therapeutics Announces the Appointment of Marc Blaustein as Chief Operating Officer
Finch Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Finch Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
Displaying 1 - 10 of 18